Avoro Capital Advisors LLC
Top Portfolio Positions
30 positions ·
$10,853,621,123 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| UTHR |
UNITED THERAPEUTICS Corp
Healthcare
|
3,010,000 | $1,784,869,800 | 16.44% | |
| ASND |
Ascendis Pharma A/S
Healthcare
|
5,062,500 | $1,157,945,625 | 10.67% | |
| MDGL |
Madrigal Pharmaceuticals, Inc.
Healthcare
|
1,818,181 | $951,763,208 | 8.77% | |
| CNTA |
Centessa Pharmaceuticals plc
Healthcare
|
22,860,910 | $908,035,344 | 8.37% | |
| KRYS |
Krystal Biotech, Inc.
Healthcare
|
2,888,888 | $746,257,548 | 6.88% | |
| ARGX |
Argenx SE
Healthcare
|
1,000,000 | $730,250,000 | 6.73% | |
| ARWR |
Arrowhead Pharmaceuticals, Inc.
Healthcare
|
10,699,999 | $670,889,937 | 6.18% | |
| KYMR |
Kymera Therapeutics, Inc.
Healthcare
|
7,474,747 | $622,571,677 | 5.74% | |
| APLS |
Apellis Pharmaceuticals, Inc.
Healthcare
|
12,222,222 | $491,699,991 | 4.53% | |
| CELC |
Celcuity Inc.
Healthcare
|
3,575,000 | $408,050,500 | 3.76% |
Portfolio Trend
25 quarters · across all stocks
Holdings in CNTA
Shares Held
Position Value (USD)
7 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $454,017,672 | 11,430,455 | Shares | Sole | 2026-05-15 | |
| 2026-03-31 | $454,017,672 | 11,430,455 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $364,034,430 | 14,555,555 | Shares | Sole | 2026-03-16 | |
| 2025-09-30 | $262,095,940 | 10,808,080 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $65,700,000 | 5,000,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $58,239,000 | 4,050,000 | Shares | Sole | 2025-05-15 | |
| 2021-06-30 | $11,105,000 | 500,000 | Shares | Sole | 2021-08-16 | |
| No 13F history on record for this holder in this stock. | ||||||